Resmed Inc (RMD) Gross Margin (2009 - 2026)

Resmed (RMD) has reported Gross Margin for 18 consecutive years, with 58.84% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin fell 200.0% year-over-year to 58.84%; the trailing twelve-month figure through Jun 2026 stood at 61.06% (up 169.0% YoY), and the FY2026 full-year result was 61.06%, up 169.0% from the prior year.
• Gross Margin fell to 58.84% in Q2 2026 per RMD's latest filing, from 62.25% in the prior quarter.
• Across five years, Gross Margin topped out at 62.25% in Q1 2026 and bottomed at 54.44% in Q3 2023.
• Historically, Gross Margin has averaged 58.07% across 5 years, with a median of 58.19% in 2024.
• The sharpest annual moves came in 2023 and 2024: Gross Margin tumbled 247 bps in 2023, then surged 414 bps in 2024.
• Over 5 years, Gross Margin stood at 56.08% in 2022, then dropped by 1 bps to 55.64% in 2023, then gained by 5 bps to 58.6% in 2024, then increased by 5 bps to 61.76% in 2025, then fell by 5 bps to 58.84% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 58.84%, 62.25%, and 61.76% for Q2 2026, Q1 2026, and Q4 2025 respectively.